Delta-8 Tetrahydrocannabinol Exposures Reported to US Poison Centers: Variations Among US States and Regions and Associations with Public Policy

被引:1
|
作者
Smith, Gary A. [1 ,2 ,5 ]
Burgess, Alice [1 ,3 ]
Badeti, Jaahnavi [1 ]
Rine, Natalie I. [4 ]
Gaw, Christopher E. [1 ,2 ]
Middelberg, Leah K. [1 ,2 ]
Spiller, Henry A. [4 ]
Hays, Hannah L. [1 ,2 ,4 ]
机构
[1] Nationwide Childrens Hosp, Ctr Injury Res & Policy, Abigail Wexner Res Inst, 700 Childrens Dr, Columbus, OH 43205 USA
[2] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA
[3] Univ Colorado, Sch Med, Denver, CO USA
[4] Nationwide Childrens Hosp, Cent Ohio Poison Ctr, Columbus, OH USA
[5] Child Injury Prevent Alliance, Columbus, OH 43230 USA
关键词
Delta-8; Tetrahydrocannabinol; Public Policy; Regulation; Poisoning; DELTA(8)-THC;
D O I
10.1007/s13181-024-01030-z
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Introduction This study investigated exposures involving triangle 8-tetrahydrocannabinol (triangle 8-THC) reported to US poison centers (PCs), including variation among states and regions. It evaluated whether the triangle 8-THC exposure rate was lower among states with triangle 8-THC regulations and states where cannabis (triangle 9-THC) use was legal. Methods National Poison Data System data for triangle 8-THC exposures in 2021-2022 were analyzed, including comparisons of state and regional population-based exposure rates. Results There were 4,925 exposures involving triangle 8-THC as the primary substance reported to US PCs from January 1, 2021, to December 31, 2022, with 69.8% of these reported in the US South. The rate of exposure per 100,000 US population increased by 79.2% from 0.53 in 2021 to 0.95 in 2022. In 2022, the mean rate of triangle 8-THC exposures in states where cannabis use was illegal was 1.64 per 100,000 population (95% CI: 1.08-2.20) compared with 0.52 (95% CI: 0.29-0.76) in states where cannabis use was legal (P = 0.0010). In 2022, the mean rate of triangle 8-THC exposures in states where triangle 8-THC was unregulated was 1.36 per 100,000 population (95% CI: 0.95-1.77) compared with 0.17 (95% CI: 0.06-0.27) in states where triangle 8-THC was banned (P < 0.0001). Conclusions The rate of triangle 8-THC exposures reported to US PCs increased by 79% from 2021 to 2022, with the US South accounting for more than two-thirds of exposures. The rate of triangle 8-THC exposures reported to PCs was significantly lower among states where triangle 8-THC was banned and among states where cannabis use was legal. Consistent regulation of triangle 8-THC across all states should be adopted.
引用
收藏
页码:389 / 400
页数:12
相关论文
共 50 条
  • [31] Pediatric meclizine exposures reported to US poison centers nationwide
    Pancioli, Breanna
    Colvin, Jonathan
    Goertemoeller, Sheila
    Yin, Shan
    CLINICAL TOXICOLOGY, 2023, 61 : 157 - 157
  • [32] Mapping scorpion exposures reported to US poison control centers
    Kang, A. Min
    Brooks, Daniel
    CLINICAL TOXICOLOGY, 2017, 55 (07) : 821 - 822
  • [33] Trends and Characteristics of Fentanyl Exposures Reported to the US Poison Centers
    Rege, S., V
    Kopatic, M.
    Michienzi, A.
    Holstege, C.
    ANNALS OF EMERGENCY MEDICINE, 2020, 76 (04) : S101 - S102
  • [34] Poison hemlock exposures reported to US poison centers 2010-2020
    Wadman, Victoria
    Smith, Karen
    Lyden, Elizabeth
    Kirschner, Ronald
    CLINICAL TOXICOLOGY, 2022, 60 : 69 - 70
  • [35] Exposures to newer injectable diabetes medications reported to United States (US) poison control centers
    Thomas, Karen C.
    Crouch, Barbara I.
    CLINICAL TOXICOLOGY, 2012, 50 (07) : 684 - 685
  • [36] Toxicity and clinical outcomes of paliperidone exposures reported to US Poison Centers
    Tsay, M. E.
    Klein-Schwartz, W.
    Anderson, B.
    CLINICAL TOXICOLOGY, 2014, 52 (03) : 207 - 213
  • [37] 15 years of vitamin D exposures reported to US Poison Centers
    Spiller, Henry A.
    Good, Theodore F.
    Aleguas, Alfred
    CLINICAL TOXICOLOGY, 2015, 53 (04) : 242 - 242
  • [38] The toxicity and clinical outcomes of paliperidone exposures reported to US poison centers
    Tsay, Mingzohn E.
    Anderson, Bruce
    Gonzales, Larry
    Klein-Schwartz, Wendy
    CLINICAL TOXICOLOGY, 2013, 51 (07) : 708 - 708
  • [39] An analysis of exposures to medications contraindicated in pregnancy reported to US poison centers
    Minhaj, Faisal
    Leonard, James
    Paterson, Emily
    Klein-Schwartz, Wendy
    CLINICAL TOXICOLOGY, 2022, 60 : 31 - 31
  • [40] A review of tapentadol exposures in adult patients as reported to US poison centers
    Stanton, M.
    Drott, T.
    Gummin, D.
    Borys, D.
    CLINICAL TOXICOLOGY, 2014, 52 (07) : 797 - 797